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Editorial on the Research Topic
Adipose Tissue: Which Role in Aging and Longevity?
Since 2018, we are living in a world where there are more people over age 65 than there are children
under five. Predictions indicate, if this trend continues, by the year 2050, the number of people
over 65 will be double the number of people under five (1). Consequently, an understanding of
the optimal physiological, endocrinological, and anthropometric conditions associated with better
health during aging is to be considered a priority topic. In parallel with the increasing aging of the
population, there is a parallel increase of overweight and obese individuals among older adults (2).
Normal aging involves important changes to body composition, including decreased muscle
mass and increased fat mass (3). Basal metabolism, for the majority of the elderly, is the main daily
energetic expenditure and its decrease with age provides one explanation for the tendency to gain
weight, with age. In addition to this physiological statement, lifestyle changes in aged people and the
associated reduction in physical activity level favors weight increase with age. Total body fat peaks
at about 65–70 years, while in advanced old age it decreases. Aging, indeed, modifies adipose tissue
accumulation and redistribution resulting in accumulation of abdominal fat. These age-related
changes alter many physiological functions including inflammation and contribute to age-related
diseases such as cardiovascular events, diabetes mellitus, hypertension, stroke, and several types of
cancer (4). However, to what extent, the age-related adipose tissue remodeling impacts the health
status in elderly is incompletely understood.
To highlight and clarify the main age-related changes in adipose tissue and discuss its
implications on health status with particular regard to age-related diseases, we dedicated a Research
Topic to the alteration of lipid storage, the redistribution and the types of fat, the production of
different mediators contributing to a pro-inflammatory status in aging.
Conte et al. are setting the stage, discussing the evident evolutionarily advantage provided by
this tissue common among all animal species. Maintaining the correct distribution of body fat
seems crucial for health and longevity. Interestingly, it seems that while a lower threshold of fat
mass exists, it does not appear existing an upper one. In human and in many animals, adipose
tissue can be accumulated in very large amounts. Most probably, an upper limit was not established
by natural selection because a large accumulation of body fat in the wild is uncommon, unlike what
we are observing during modern times in our species. Although the health implication of excessive
body fat is evident, as they discuss, they also propose that a suitable amount of fat is probably an
important feature for reaching extended longevity (Conte et al.).
Because of its simplicity, BMI is broadly used as a surrogate for body fat, although it is
highly imprecise. For example, a bodybuilder with a low percentage of body fat could fall in the
obese category. Ponti et al. present how body composition is different at different ages, stressing
that there is not only an increase in body fat but also a redistribution of body mass with age.
Lorenzini et al. Editorial: Adipose Tissue in Aging
In particular, fat mainly increases in the trunk (largely visceral
fat), but not in arms or legs. A major difference also exists
between male and female older adults likely contributing to
the sex-difference in the prevalence of age-related diseases.
An accurate assessment of body composition is critical to
discriminate an increase/decrease of fat rather than muscle
mass in the elderly. Ponti et al., review the most precise
methods available for the clinic and for research to determine
body composition [dual-energy X-ray absorptiometry (DXA),
ultrasound, computed tomography (CT) andmagnetic resonance
imaging (MRI)] outlining advantages and disadvantages of
each technique.
Zoico et al. focus on the significance of changes happening
during aging in two subcategories of body fat: brown adipose
tissue (BAT) and beige adipose tissue, fat tissues rich in
mitochondria with the univocal (brown) or conditional (beige)
function of converting stored energy into heat.
Adipose tissue is a recognized endocrine organ, producing
a variety of adipokines, whose levels tend to increase with
aging. Mancuso and Bouchard have provided a comprehensive
overview of adipokine functions, classifying them as pro-
inflammatory (leptin, resistin, chemerin, retinol binding protein
4, lipocalin 2, CCL2, IL-1β, IL-6, IL-12, IL-18, and TNF-α) and
anti-inflammatory (adiponectin, vaspin, secreted-frizzled-related
protein 5, omentin-1 C1q/TNF-related proteins).
Arai et al. focus on the roles and significance of adiponectin,
an adipokine whose levels are elevated in centenarians. In
contrast to the majority of other adipokines, its plasma levels are
inversely related to body fat. In this report, the authors describe
how this adipokine is considered highly beneficial for longevity,
possibly contributing to enhancing insulin sensitivity. They
also describe some interesting paradoxes related to adiponectin
that challenge its beneficial role: the observed association
between higher adiponectin level and mortality in patients with
cardiovascular disease and with frailty in elderly subjects. They
propose a solution to these paradoxes introducing the concept of
adiponectin resistance: higher adiponectin levels, in their view, is
possibly a compensatorymechanism in response to inflammation
and oxidative stress.
In light of the current SARS-CoV-2 pandemic affecting
prevalently the elderly (5), an important topic is the role
of the process of aging in the susceptibility to infectious
diseases. Obesity, as it increases with age, exerts a cumulative
effect. Obese individuals are increasingly vulnerable to fungal,
bacterial, and viral infection. Frasca and McElhaney present an
overview of the roles of obesity on the immune response to
respiratory tract infection. Specifically, they analyze the risk for
the elderly represented by pneumococcus infection, highlighting
the presence of an interesting obesity paradox: it appears that
obesity is protective against the more serious complications of
this bacterial infection. This stresses the need to investigate
further, how obesity is modulating our immune response (Frasca
and McElhaney).
Salvestrini et al. look from further away at the
interrelationship between excess body fat and aging. Their
considerations stem from a reflection on the experimental
paradigm of life span extension by caloric restriction, specifically
on how best to consider control animals when translating
experimental results to human (6). If a control animal, ad libitum
fed, has to be considered an animal with no excess fat, equivalent
to a normal weight human (BMI between 18.5 and 24.9) than
to benefit from the lifespan-extending effect of CR, a human
should approach underweight. If, instead, as many authors are
proposing [reviewed in (6)], control animals in many instances
should be considered the equivalent of obese humans, then the
lifespan-extending capacity of CR is simply communicating that
obesity has a life shortening effect, which is well-known from
epidemiological evidence. From these considerations Salvestrini
et al. have looked at obesity under the lens of the hallmarks of
aging as listed by López-Otín et al. (7); the vast collection of
literature they overviewed, demonstrates an impressive overlap
between the process of aging and the metabolic consequences of
excess body fat (Salvestrini et al.).
Although the increase of body fat with age remains a major
risk factor for age-related diseases, several studies are needed to
disentangle the complex network of metabolic, endocrinological,
and immunological mediators that are involved. Moreover,
the general increase of the elderly population leads to the
consequent increase of 90+ elderly and centenarians. Many
studies demonstrated the peculiarity of these individuals (8, 9),
however little is known about the amount and kind of adipose
tissue they have. Future researches are needed to investigate the
age-related remodeling of body fat including also very old people.
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